The present disclosure relates to antibodies directed to vascular endothelial growth factor (“VEGF”) and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF.

Edits on 12 Jul, 2023

"update inverses"

Golden AI

edited on 12 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11697801 AAV-mediated delivery of therapeutic antibodies to the inner ear

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=09079953

Edits on 22 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09079953 Anti-VEGF antibodies and their uses US Patent 9079953 Anti-VEGF antibodies and their uses

Infobox

Patent Number

09079953

Patent Number

9079953

Edits on 8 Jun, 2022

"Entity importer update"

Golden AI

edited on 8 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09079953

Edits on 2 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 2 Jan, 2022

Edits made to:

Infobox (+7 properties)

‌

US Patent 09079953 Anti-VEGF antibodies and their uses

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09079953

Date of patent

July 14, 2015

Patent application number

12817800

Date Filed

June 17, 2010

Patent primary examiner

‌

Phuong Huynh

Find more entities like US Patent 9079953 Anti-VEGF antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.